Kavar Capital Partners Group’s Sanofi SNY Stock Holding History

Kavar Capital Partners Group’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-53	Closed	-$2K	–	349
2015 Q4	$2K	Hold	53	–	–	﹤0.01%	367
2015 Q3	$2K	Hold	53	–	–	﹤0.01%	367
2015 Q2	$2K	Buy	+53	New	+$2.69K	﹤0.01%	399
2014 Q2	–	Sell	-52	Closed	-$2K	–	389
2014 Q1	$2K	Buy	52 +6	+13%	+$304	﹤0.01%	402
2013 Q4	$2K	Buy	+46	New	+$2.37K	﹤0.01%	387

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Kavar Capital Partners Group's SNY Position: Q1 2016 in Review

Kavar Capital Partners Group sold out of Sanofi (SNY) in Q1 2016, closing a stake of 53 shares — an estimated $2K sold.

Kavar Capital Partners Group first reported a position in SNY in Q4 2013 and held it in 5 quarters. The position peaked at $2K in Q4 2015. 449 funds tracked by Wall St. Rank hold SNY as of Q1 2016.

Kavar Capital Partners Group reported no remaining Sanofi position as of Q1 2016 after selling out during the quarter.
Kavar Capital Partners Group sold 53 Sanofi shares in Q1 2016, an estimated $2K.
Kavar Capital Partners Group first reported a position in Sanofi in Q4 2013 and held it in 5 quarters.
Kavar Capital Partners Group's Sanofi position peaked at $2K in Q4 2015.
449 funds tracked by Wall St. Rank held Sanofi as of Q1 2016.

Based on Kavar Capital Partners Group's 13F filing for Q1 2016, filed 13 May 2019.